• Ponazuril with Low Price CAS 9004-4-2 with Large Stock
  • Ponazuril with Low Price CAS 9004-4-2 with Large Stock
  • Ponazuril with Low Price CAS 9004-4-2 with Large Stock
  • Ponazuril with Low Price CAS 9004-4-2 with Large Stock
  • Ponazuril with Low Price CAS 9004-4-2 with Large Stock
  • Ponazuril with Low Price CAS 9004-4-2 with Large Stock

Ponazuril with Low Price CAS 9004-4-2 with Large Stock

Powder: Yes
Customized: Customized
Certification: GMP, HSE, ISO 9001, USP, BP
Suitable for: Elderly, Children, Adult
State: White Powder
Purity: >99%
Samples:
US$ 50/Bag 1 Bag(Min.Order)
| Request Sample
Customization:
Manufacturer/Factory
Gold Member Since 2021

Suppliers with verified business licenses

Shaanxi, China
Importers and Exporters
The supplier has import and export rights
High Repeat Buyers Choice
More than 50% of buyers repeatedly choose the supplier
Experienced Team
The supplier has 6 foreign trading staff(s) and 3 staff(s) with over 6 years of overseas trading experience
Patents Awarded
The supplier had awarded 1 patents, you can check the Audit Report for more information
to see all verified strength labels (10)

Basic Info.

Model NO.
Frazer-Ponazuril
Appearance
White Powder
CAS No
42971-09-5
Shelf Life
2 Years
Test Method
HPLC
MOQ
1kg
Storage
Store Cool Dry Place
Resource
Natural
Quality Requirement
Strictly Quality Control
Transport Package
Foil Bag
Specification
99%
Trademark
Xi′an Frazer Biotech Co., Ltd.
Origin
China
Production Capacity
2000kg/Month

Product Description

Ponazuril with Low Price CAS 9004-4-2 with Large Stock

Ponazuril with Low Price CAS 9004-4-2 with Large Stock
Ponazuril with Low Price CAS 9004-4-2 with Large Stock

What is Ponazuril?

Ponazuril (INN), sold by the Bayer Corporation under the trade name Marquis, is a drug currently approved for the treatment of equine protozoal myeloencephalitis (EPM) in horses, caused by Sarcocystis neurona.


Toltrazuril sulfone (Ponazuril) is a triazine-based antiprotozoal agent with clinical application in the treatment of equine protozoal myeloencephalomyelitis (EPM). It is a new drug against coccidiosis developed by the German Bayer. 

More recently, veterinarians have been preparing a formulary version of the medication for use in small animals such as cats and dogs against coccidia, an intestinal parasite. Coccidia treatment is far shorter than treatment for EPM.

Ponazuril Specification

tems Specifications Results
Character White or almost white crystalline powder;odorless white crystelline powder, odorless
Melting point 242~246°C 243.4~244.3°C
Identification 1) IR spectra is consistent with CRS complies
  2) The retention time of the major peak in the chromatogram of the assay preparation corresponds to that in the chromatogram of the standard preparation, as obtained in the assay complies
Appearance of solution colorless and clear liquid colorless and clear liquid
Related substances individual impurity≤1.0% 0.24%
  Total impuirties ≤2.0% 0.70%
Loss on ignition ≤0.5% 0.32%
Residue on ignition ≤0.1% 0.05%
Heavy metals Not more than 10 parts per million Less than 10 parts per million
Assay Not less than 98.0% of C18H14F3N3O6S(On dried basis) 99.40%
Conclusion: Complies with Ponazuril Enterprise Standard

Ponazuril with Low Price CAS 9004-4-2 with Large Stock

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Gold Member Since 2021

Suppliers with verified business licenses

Manufacturer/Factory
Registered Capital
1000000 RMB
Plant Area
501~1000 square meters